These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2084998)

  • 41. Orbital decompression of dysthyroid eye disease.
    Malins TJ; Ward-Booth RP; Allen ED
    Br J Oral Maxillofac Surg; 1990 Feb; 28(1):29-33. PubMed ID: 2182108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective review of 26 cases of dysthyroid optic neuropathy.
    Panzo GJ; Tomsak RL
    Am J Ophthalmol; 1983 Aug; 96(2):190-4. PubMed ID: 6881242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.
    Wang Y; Zhou H; Fan X
    Front Med; 2017 Sep; 11(3):359-364. PubMed ID: 28500433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inferior orbital decompression for dysthyroid optic neuropathy.
    Leone CR; Bajandas FJ
    Ophthalmology; 1981 Jun; 88(6):525-32. PubMed ID: 7267026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CT scan evidence of dysthyroid optic neuropathy.
    Giaconi JA; Kazim M; Rho T; Pfaff C
    Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):177-82. PubMed ID: 12021647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of transmedial-canthal ethmoidal decompression for severe dysthyroid optic neuropathy.
    Ohtsuka K; Nakamura Y
    Jpn J Ophthalmol; 1999; 43(5):426-32. PubMed ID: 10580667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Objective evaluation of improvement in optic neuropathy following radiation therapy for thyroid eye disease.
    Rush S; Winterkorn JM; Zak R
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):191-4. PubMed ID: 10758323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography.
    Kennerdell JS; Rosenbaum AE; El-Hoshy MH
    Arch Ophthalmol; 1981 May; 99(5):807-9. PubMed ID: 6894536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin for treatment of refractory dysthyroid compressive optic neuropathy.
    Chang S; Perry JD; Kosmorsky GS; Braun WE
    Ophthalmic Plast Reconstr Surg; 2007; 23(3):225-6. PubMed ID: 17519662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does decompression diminish the discomfort of severe dysthyroid orbitopathy?
    Khan JA; Doane JF; Whitacre MM
    Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):109-12. PubMed ID: 7654613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolution of choroidal folds and improvement in visual acuity after orbital decompression for graves orbitopathy.
    Jorge R; Scott IU; Akaishi PM; Velasco Cruz AA; Flynn HW
    Retina; 2003 Aug; 23(4):563-5. PubMed ID: 12972777
    [No Abstract]   [Full Text] [Related]  

  • 52. Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.
    Gonçalves AC; Gebrim EM; Monteiro ML
    Clinics (Sao Paulo); 2012 Nov; 67(11):1327-34. PubMed ID: 23184212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes mellitus: a risk factor in patients with Graves' orbitopathy.
    Kalmann R; Mourits MP
    Br J Ophthalmol; 1999 Apr; 83(4):463-5. PubMed ID: 10434871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Medical treatment of dysthyroid orbitopathy].
    Badelon I; Morax S
    J Fr Ophtalmol; 2004 Sep; 27(7):822-4. PubMed ID: 15499285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of acute Graves orbitopathy.
    Kazim M; Trokel S; Moore S
    Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
    Perros P; Krassas GE
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):689-91. PubMed ID: 12072037
    [No Abstract]   [Full Text] [Related]  

  • 57. Restoration of vision by radiotherapy for severe, acute, steroid-refractory, congestive thyroid orbitopathy.
    MacAndie K; Harnett AN; Kyle P
    Clin Oncol (R Coll Radiol); 2000; 12(3):188-91. PubMed ID: 10942337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Orbital radiotherapy for thyroid-related orbitopathy.
    Behbehani R; Sergott RC; Savino PJ
    Curr Opin Ophthalmol; 2004 Dec; 15(6):479-82. PubMed ID: 15523191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of dysthyroid optic neuropathy.
    Klingele TG; Hart WM; Burde RM
    Ophthalmologica; 1977; 174(6):327-35. PubMed ID: 882252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylprednisolone pulse therapy in severe dysthyroid optic neuropathy.
    Guy JR; Fagien S; Donovan JP; Rubin ML
    Ophthalmology; 1989 Jul; 96(7):1048-52; discussion 1052-3. PubMed ID: 2771352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.